Recent Advances in Synthetic Strategies and Biological Properties of Indazole Scaffolds: A Review
- PMID: 40591193
- PMCID: PMC12213994
- DOI: 10.1007/s41061-025-00509-9
Recent Advances in Synthetic Strategies and Biological Properties of Indazole Scaffolds: A Review
Abstract
Research on heterocyclic compounds is an area of continuous focus, capturing the interest of both synthetic and natural product chemists. Indazoles are one of the rare heterocycles that are available in nature. Indazole and its derivatives are one of the most important classes of heterocycles in pharmacological molecules. The structurally different indazole motifs, with impressive bioactivity, have drawn increasing attention from medicinal chemists in recent years for the continuous development of novel drug moieties. Thus, knowledge of the biological activities and synthetic pathways of indazole scaffolds is essential to enhancing further developments in the number of indazole-based lead molecules. The goal of the present review is to highlight information on the biological properties of some existing indazole-based drugs and activities of novel bioactive indazole compounds in clinical trails, with specific attention to the most recent advances in various synthetic strategies towards indazole and its derivatives over the past 7 years (2017-2024). Moreover, we discuss the substrate tolerance and mechanistic insights for most of the summarized synthetic protocols.
Keywords: Biological activities; Clinical trails; Heterocycles; Indazole; Mechanistic insights; Synthetic routes.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of Interest: The authors declare no competing interests.
Figures

































































































Similar articles
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2. Cochrane Database Syst Rev. 2020. PMID: 33075160 Free PMC article.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.Cochrane Database Syst Rev. 2001;(3):CD003234. doi: 10.1002/14651858.CD003234. Cochrane Database Syst Rev. 2001. Update in: Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003234. doi: 10.1002/14651858.CD003234.pub2. PMID: 11687058 Updated.
References
-
- Aaron DM, Musa ZN, Makhluf JH, Mark JK (2006) N,N-bond-forming heterocyclization: synthesis of 3-alkoxy-2H-indazoles. J Org Chem. 10.1021/jo0524831 - PubMed
-
- Thangadurai A, Minu M, Wakode S, Agarwal S, Narasimhan B (2012) Indazole: a medicinally important heterocyclic moiety. Med Chem Res. 10.1007/s00044-011-9631-3
-
- Catalan J, Elguero J (1987) Basicity and acidity of azoles. Adv Heterocyclic Chem. 10.1016/s0065-2725(08)60162-2
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous